Pruccoli Jacopo, Bergonzini Luca, La Tempa Angela, Parmeggiani Antonia
IRCCS Istituto Delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria Dell'Età Pediatrica, Centro Regionale per i Disturbi Della Nutrizione e dell'Alimentazione in età Evolutiva, 40138 Bologna, Italy.
Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Università di Bologna, 40138 Bologna, Italy.
Biomedicines. 2022 Dec 7;10(12):3167. doi: 10.3390/biomedicines10123167.
Evidence about the use of pharmacologic agents in the treatment of Anorexia Nervosa (AN) is lacking, especially in childhood and adolescence. A systematic scoping review was conducted to outline current literature evidence about the use of antipsychotics in this population. A total of 499 studies were identified with the initial search, and 28 of these studies were selected regarding the use of olanzapine (n = 13), risperidone (n = 4), aripiprazole (n = 3), chlorpromazine (n = 3), pimozide (n = 1) clotiapine (n = 1) and multiple antipsychotics (n = 3) in these patients. Overall, major side effects were reported infrequently; improvements in psychopathology and weight measures have been suggested in the majority of the considered studies. Nonetheless, the lack of RCT or good-quality studies strongly limits the generalizability of results in clinical practice.
关于使用药物制剂治疗神经性厌食症(AN)的证据不足,尤其是在儿童和青少年中。进行了一项系统的范围综述,以概述有关该人群使用抗精神病药物的当前文献证据。初步检索共识别出499项研究,其中28项研究涉及这些患者使用奥氮平(n = 13)、利培酮(n = 4)、阿立哌唑(n = 3)、氯丙嗪(n = 3)、匹莫齐特(n = 1)、氯噻平(n = 1)和多种抗精神病药物(n = 3)的情况。总体而言,很少报告有严重副作用;在大多数纳入研究中,已表明精神病理学和体重指标有所改善。尽管如此,缺乏随机对照试验或高质量研究严重限制了研究结果在临床实践中的可推广性。